共 25 条
[1]
Ganz ML(2010)Economic costs of overactive bladder in the United States Urology 75 526-532
[2]
Smalarz AM(2006)The placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms Eur Urol 50 440-452
[3]
Krupski TL(2001)Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study J Urol 165 1193-1198
[4]
Van Leeuwen JH(2009)Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the Overactive Bladder Innovative Therapy Trial J Urol 182 1055-1061
[5]
Castro R(2009)Percutaneous tibial nerve stimulation for the treatment of urinary frequency, urinary urgency, and urge incontinence: results from a community-based clinic Urol Nurs 29 177-185
[6]
Busse M(2009)The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction Neurourol Urodyn 28 964-968
[7]
Bemelmans BL(2004)Finazzi Agrò E, et al.: Posterior tibial nerve stimulation in the treatment of voiding dysfunction: urodynamic data Neurourol Urodyn 23 246-251
[8]
Govier FE(2010)Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder J Urol 183 234-240
[9]
Litwiller S(2008)A review of adherence to drug therapy in patients with overactive bladder BJU Int 102 774-779
[10]
Nitti V(undefined)undefined undefined undefined undefined-undefined